Aldosterone-induced vasculopathy: a new reversible cause of cardiac death.
about
Antifailure therapy including spironolactone improves left ventricular energy supply-demand relations in nonischemic dilated cardiomyopathy.The role of aldosterone in heart failure and the clinical benefits of aldosterone blockade.The role of renin-angiotensin-aldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection.
P2860
Aldosterone-induced vasculopathy: a new reversible cause of cardiac death.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Aldosterone-induced vasculopathy: a new reversible cause of cardiac death.
@ast
Aldosterone-induced vasculopathy: a new reversible cause of cardiac death.
@en
Aldosterone-induced vasculopathy: a new reversible cause of cardiac death.
@nl
type
label
Aldosterone-induced vasculopathy: a new reversible cause of cardiac death.
@ast
Aldosterone-induced vasculopathy: a new reversible cause of cardiac death.
@en
Aldosterone-induced vasculopathy: a new reversible cause of cardiac death.
@nl
prefLabel
Aldosterone-induced vasculopathy: a new reversible cause of cardiac death.
@ast
Aldosterone-induced vasculopathy: a new reversible cause of cardiac death.
@en
Aldosterone-induced vasculopathy: a new reversible cause of cardiac death.
@nl
P2860
P356
P1476
Aldosterone-induced vasculopathy: a new reversible cause of cardiac death.
@en
P2093
Struthers AD
P2860
P304
P356
10.3317/JRAAS.2001.033
P577
2001-12-01T00:00:00Z